Seres Therapeutics
MCRB
MCRB
76 hedge funds and large institutions have $60M invested in Seres Therapeutics in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 27 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
18% less funds holding
Funds holding: 93 → 76 (-17)
41% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 27
68% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 25
Holders
76
Holding in Top 10
1
Calls
$1.21M
Puts
$607K
Top Buyers
| 1 | +$597K | |
| 2 | +$374K | |
| 3 | +$354K | |
| 4 |
CF
Cantor Fitzgerald
New York
|
+$265K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$241K |
Top Sellers
| 1 | -$2.09M | |
| 2 | -$727K | |
| 3 | -$715K | |
| 4 |
Jane Street
New York
|
-$649K |
| 5 |
Goldman Sachs
New York
|
-$617K |